Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease

  • 0Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. rthandassery@uams.edu.

|

|

Summary

This summary is machine-generated.

Baveno VI criteria (BC) and expanded BC (EBC) effectively identify patients with compensated advanced chronic liver disease (cACLD) who need treatment for esophageal varices (EV). These noninvasive scores can help spare patients from unnecessary endoscopies while maintaining high accuracy.

Area Of Science

  • Hepatology
  • Gastroenterology
  • Diagnostic Accuracy

Background

  • Compensated advanced chronic liver disease (cACLD) carries a risk of gastroesophageal varices.
  • Noninvasive scoring systems aim to identify patients with cACLD who require endoscopic screening for clinically significant portal hypertension (CSPH).
  • Comparative data on the accuracy of these scores for predicting CSPH, specifically esophageal varices (EV) and varices needing treatment (VNT), are limited.

Purpose Of The Study

  • To directly compare the diagnostic accuracy of various noninvasive scoring systems for predicting CSPH (EV and VNT) in patients with cACLD.
  • To evaluate the ability of Baveno VI criteria (BC) and expanded BC (EBC) to spare patients from esophagogastroduodenoscopy (EGD).

Main Methods

  • A cohort of patients with cACLD was assessed.
  • The predictive performance of Baveno VI criteria (BC), expanded BC (EBC), AST-Platelet Ratio Index, MELD-Na, liver stiffness measurement, FIB-4, CHESS-ALARM score, and FIB-5 score for EV and VNT was compared.
  • The rate of esophagogastroduodenoscopy (EGD) avoidance and miss rates for EV and VNT were calculated.

Main Results

  • BC and EBC demonstrated accuracy in identifying patients with EV, gastric varices (GV), and VNT.
  • BC allowed EGD sparing in 48% of patients with a 6.4% miss rate for EV; EBC spared EGD in 60% with a 0% miss rate for VNT.
  • BC, EBC, CHESS-ALARM score, and FIB-5 score independently predicted EV and VNT, with similar performance across metabolic dysfunction-associated steatotic liver disease (MASLD) and non-MASLD groups, as well as in obese and nonobese subgroups.

Conclusions

  • BC and EBC are valuable tools for sparing EGD in patients with cACLD, offering low miss rates for EV, GV, and VNT.
  • The performance of BC and EBC was consistent regardless of MASLD status or obesity.
  • CHESS-ALARM score and FIB-5 score show high accuracy in predicting CSPH (EV and VNT) in patients with cACLD.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management 01:28

147

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Esophageal Varices-I: Introduction 01:24

354

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

Varicose Veins II: Diagnostic Studies and Interprofessional Care 01:26

37

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

Barrett Esophagus-II: Clinical Manifestations and Management 01:21

315

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

Barrett Esophagus-I: Introduction 01:21

219

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

Ultrasound II: Endoscopic Ultrasound and FibroScan 01:25

209

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...